Stay On Top of COVID-19 Vaccine Guidance
March 2024
You’re in a key spot to promote the XBB.1.5 COVID-19 vaccine for patients previously unvaccinated or those needing a spring dose.
Only about 15% of Canadians have received an XBB.1.5 vaccine.
Explain that patients who receive an XBB.1.5 COVID-19 vaccine are expected to have a better immune response against current circulating variants, including subvariants JN.1 and HV.1.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive